Tribune published in El Economista
Our CEO, Juan Carlos de Gregoriohas had the opportunity to publish in The Economist a forum where he shares his vision on the current treatments for pancreatic cancer, as well as the new approach proposed by Peaches against this type of cancer, which has specific immunological particularities.
Our research is based on Peaches Biotech’s exclusive rights to the Harvard Medical School BIDMC patent that allows activation of a patient’s lymphocytes against their own tumor cells, in a completely autologous process.
Advances in the understanding of cancer immunobiology and the critical role of the tumor microenvironment in paralyzing the immune system have opened new horizons in cancer therapeutics.
A large multinational team of scientists brings our company closer to achieving its goal every day.
If you want to read the rest of the tribune, here is the link.